We just scored a big gain in recently recommended Western Digital, and think we found another beaten up tech stock about to do the same thing. Read More

We are not turning bearish on biotech at this point. But we do think it’s a good time to be patient and to consider some portfolio protection. Read More

EMC Corp. (NYSE: EMC), whose storage solutions already help to alleviate this data glut, has been innovating and integrating new technologies in order to secure its position as the largest data storage provider in the world. Read More

Turmoil surrounding the Greek debt crisis has brought one of our favorite stocks back down to an attractive level, so we are once again adding it our Investments Portfolio. Read More

In this issue:In Depth:  New EBIS Buy:  Meridian Biosciences (VIVO)Portfolio Update: News on Repligen, Medivation, News Update:   Are Migraines the Next Biotech Frontier?This week we are featuring two Big Picture charts as an interesting relationship is developing between the biotech sector and the bond market.  The Nasdaq Biotech Index (NBI) delivered… Read More

All told, over 2.5 million Americans are candidates for exoskeletons currently available or already under development. With only about 250 sold to date – and sales accelerating each month – the potential is virtually limitless. Read More

A common criticism of tech stocks is that too many of them are "priced for perfection", but even more puzzling to us are those tech companies that appear to be priced for imperfection, such as this one. Read More

It’s hard to believe that the biotech sector, known for its inherent volatility, is an island of relative stability in an increasingly volatile stock market. Read More

Now that the Memorial Day weekend is in our rear view mirror, it is fair to ask if the old stock market adage, “Sell in May and then go away” will turn out to be good advice for tech stocks this year. They certainly have had a very nice run… Read More

Equity Trades Portfolio Updateby Joe Duarte, M.D.Buy AlertsEarnings UpdateNews Update: It’s ASCO Conference SeasonM & A UpdateThe biotech sector rebounded on the week that ended on May 8th. Behind another merger announcement and some mixed economic news, the worries about the Federal Reserve raising interest rates… Read More